SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Janel Corp – ‘10-K’ for 9/30/19 – ‘R41’

On:  Tuesday, 1/28/20, at 5:31pm ET   ·   For:  9/30/19   ·   Accession #:  1140361-20-1614   ·   File #:  333-60608

Previous ‘10-K’:  ‘10-K’ on 7/26/19 for 9/30/18   ·   Next:  ‘10-K’ on 1/13/21 for 9/30/20   ·   Latest:  ‘10-K’ on 12/8/23 for 9/30/23   ·   1 Reference:  By:  Janel Corp. – Next ‘10-K’ on 1/13/21 for 9/30/20

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/28/20  Janel Corp                        10-K        9/30/19   88:8.1M                                   Broadridge Fin’l So… Inc

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    857K 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     34K 
 3: EX-21       Subsidiaries List                                   HTML     24K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     25K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
55: R1          Document and Entity Information                     HTML     61K 
24: R2          Consolidated Balance Sheets                         HTML    132K 
33: R3          Consolidated Balance Sheets (Parenthetical)         HTML     53K 
83: R4          Consolidated Statements of Operations               HTML    106K 
58: R5          Consolidated Statements of Changes in               HTML    114K 
                Stockholders' Equity                                             
27: R6          Consolidated Statements of Cash Flows               HTML    141K 
36: R7          Consolidated Statements of Cash Flows               HTML     26K 
                (Parenthetical)                                                  
84: R8          Summary of Business and Significant Accounting      HTML     77K 
                Policies                                                         
52: R9          Acquisitions                                        HTML     78K 
16: R10         Property and Equipment                              HTML     40K 
44: R11         Inventory                                           HTML     34K 
75: R12         Intangible Assets                                   HTML     40K 
66: R13         Goodwill                                            HTML     33K 
15: R14         Notes Payable - Banks                               HTML     64K 
43: R15         Subordinated Promissory Notes                       HTML     30K 
74: R16         Stockholders' Equity                                HTML     40K 
65: R17         Stock-Based Compensation                            HTML     92K 
17: R18         Income Per Common Share                             HTML     67K 
42: R19         Income Taxes                                        HTML     58K 
88: R20         PROFIT SHARING AND 401(k) PLANS                     HTML     30K 
60: R21         Business Segment Information                        HTML     73K 
32: R22         Commitments and Contingencies                       HTML     31K 
41: R23         Risks and Uncertainties                             HTML     31K 
87: R24         Subsequent Events                                   HTML     27K 
59: R25         Summary of Business and Significant Accounting      HTML    122K 
                Policies (Policies)                                              
31: R26         Basis of Presentation and Significant Accounting    HTML     30K 
                Policies (Tables)                                                
40: R27         Acquisitions (Tables)                               HTML     72K 
86: R28         Property and Equipment (Tables)                     HTML     40K 
61: R29         Inventory (Tables)                                  HTML     35K 
63: R30         Intangible Assets (Tables)                          HTML     43K 
70: R31         Goodwill (Tables)                                   HTML     32K 
45: R32         Notes Payable - Banks (Tables)                      HTML     52K 
18: R33         Stock-Based Compensation (Tables)                   HTML     91K 
64: R34         Income Per Common Share (Tables)                    HTML     68K 
71: R35         Income Taxes (Tables)                               HTML     64K 
46: R36         Business Segment Information (Tables)               HTML     74K 
19: R37         Commitments and Contingencies (Tables)              HTML     29K 
62: R38         Summary of Business and Significant Accounting      HTML    108K 
                Policies (Details)                                               
73: R39         ACQUISITIONS, Global Trading Resources, Inc         HTML     63K 
                (Details)                                                        
56: R40         ACQUISITIONS, Aves Labs, Inc. (Details)             HTML     93K 
81: R41         ACQUISITIONS, Antibodies Incorporated (Details)     HTML    107K 
34: R42         ACQUISITIONS, 2019 Acquisitions (Details)           HTML     35K 
25: R43         ACQUISITIONS, Honor Worldwide Logistics, LLC        HTML     96K 
                (Details)                                                        
57: R44         ACQUISITIONS, PhosphoSolutions (Details)            HTML     91K 
82: R45         ACQUISITIONS, Other Acquisitions (Details)          HTML     32K 
35: R46         Property and Equipment (Details)                    HTML     64K 
26: R47         Inventory (Details)                                 HTML     40K 
53: R48         INTANGIBLE ASSETS, Summary of Intangible Assets     HTML     46K 
                (Details)                                                        
85: R49         INTANGIBLE ASSETS, Future Amortization of           HTML     41K 
                Intangible assets (Details)                                      
78: R50         Goodwill (Details)                                  HTML     33K 
68: R51         NOTES PAYABLE - BANKS, Presidential Financial       HTML     33K 
                Corporation Facility (Details)                                   
21: R52         NOTES PAYABLE - BANKS, Santander Bank Facility      HTML     68K 
                (Details)                                                        
48: R53         NOTES PAYABLE - BANKS, First Merchants Bank Credit  HTML     94K 
                Facility (Details)                                               
77: R54         NOTES PAYABLE - BANKS, First Northern Bank of       HTML     88K 
                Dixon (Details)                                                  
67: R55         Subordinated Promissory Notes (Details)             HTML     46K 
20: R56         STOCKHOLDERS' EQUITY, Shares Authorized and Par     HTML     33K 
                Value (Details)                                                  
47: R57         STOCKHOLDERS' EQUITY, Preferred Stock (Details)     HTML    111K 
76: R58         STOCKHOLDERS' EQUITY, Treasury Stock, Stock         HTML     63K 
                Warrants and Indco Dividend (Details)                            
69: R59         STOCK-BASED COMPENSATION, Expense and Authorized    HTML     36K 
                (Details)                                                        
29: R60         STOCK-BASED COMPENSATION, Assumptions (Details)     HTML     52K 
39: R61         STOCK-BASED COMPENSATION, Summary of Stock Options  HTML    102K 
                (Details)                                                        
80: R62         STOCK-BASED COMPENSATION, Restricted Stock          HTML     72K 
                (Details)                                                        
51: R63         INCOME PER COMMON SHARE, Reconciliation of Basic    HTML     88K 
                and Diluted EPS (Details)                                        
28: R64         INCOME PER COMMON SHARE, Potentially Diluted        HTML     36K 
                Securities (Details)                                             
38: R65         INCOME TAXES, Reconciliation of Income Tax          HTML     43K 
                (Details)                                                        
79: R66         INCOME TAXES, Provision for Income Taxes (Details)  HTML     33K 
50: R67         INCOME TAXES, Components of Net Deferred Tax        HTML     56K 
                Assets and Liabilities (Details)                                 
30: R68         INCOME TAXES, Net Operating Loss Carryforwards      HTML     32K 
                (Details)                                                        
37: R69         Profit Sharing and 401(k) PLANS (Details)           HTML     34K 
49: R70         Business Segment Information (Details)              HTML     70K 
23: R71         Commitments and Contingencies (Details)             HTML     40K 
72: XML         IDEA XML File -- Filing Summary                      XML    152K 
54: EXCEL       IDEA Workbook of Financial Reports                  XLSX     98K 
 9: EX-101.INS  XBRL Instance -- janl-20190930                       XML   2.13M 
11: EX-101.CAL  XBRL Calculations -- janl-20190930_cal               XML    302K 
12: EX-101.DEF  XBRL Definitions -- janl-20190930_def                XML   1.12M 
13: EX-101.LAB  XBRL Labels -- janl-20190930_lab                     XML   2.03M 
14: EX-101.PRE  XBRL Presentations -- janl-20190930_pre              XML   1.52M 
10: EX-101.SCH  XBRL Schema -- janl-20190930                         XSD    201K 
22: ZIP         XBRL Zipped Folder -- 0001140361-20-001614-xbrl      Zip    248K 


‘R41’   —   ACQUISITIONS, Antibodies Incorporated (Details)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.19.3.a.u2
ACQUISITIONS, Antibodies Incorporated (Details) - USD ($)
$ in Thousands
12 Months Ended
Business Combination, Consideration Transferred [Abstract]        
Consideration transferred $ 430      
Consideration paid in cash     $ 6,179 $ 7,386
Revenue     84,354 67,521
Cost of goods sold     59,248 47,209
Selling, general and administrative     22,612 18,618
Net income     616 248
Fair Value Assets Acquired and Liabilities Assumed [Abstract]        
Goodwill     $ 13,525 11,458
Antibodies Incorporated [Member]        
Business Combination, Consideration Transferred [Abstract]        
Consideration transferred   $ 4,879    
Cash   56    
Consideration paid in cash   4,535    
Cash provided by normal operations   1,169    
Acquisition expenses       263
Revenue       1,348
Cost of goods sold       512
Selling, general and administrative       658
Interest expense       40
Net income       $ 138
Fair Value Assets Acquired and Liabilities Assumed [Abstract]        
Accounts receivable   411    
Inventory   1,102    
Prepaids   43    
Property & equipment, net   3,373    
Goodwill   675    
Accounts payable   (363)    
Accrued expenses   (235)    
Deferred income taxes   (805)    
Purchase price, net of cash received   4,879    
Antibodies Incorporated [Member] | Series C Preferred Stock [Member]        
Business Combination, Consideration Transferred [Abstract]        
Consideration transferred - Equity   1,399    
Antibodies Incorporated [Member] | Subordinated Promissory Notes [Member]        
Business Combination, Consideration Transferred [Abstract]        
Consideration transferred - Liabilities incurred   344    
Antibodies Incorporated [Member] | Senior Subordinated Loans [Member]        
Business Combination, Consideration Transferred [Abstract]        
Consideration transferred - Liabilities incurred   2,025    
Antibodies Incorporated [Member] | Trademark [Member]        
Fair Value Assets Acquired and Liabilities Assumed [Abstract]        
Intangibles   301    
Antibodies Incorporated [Member] | Other [Member]        
Fair Value Assets Acquired and Liabilities Assumed [Abstract]        
Intangibles   $ 377    

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:1/28/20
For Period end:9/30/19NT 10-K,  NT 10-K/A
7/1/19
9/30/1810-K,  NT 10-K
6/22/18
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/13/21  Janel Corp.                       10-K        9/30/20   96:8.6M                                   Broadridge Fin’l So… Inc
Top
Filing Submission 0001140361-20-001614   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 7:51:07.1pm ET